National Association for Proton Therapy establishes Physician Advisory Committee

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

To guide the National Association for Proton Therapy, the organization has created a Physician Advisory Committee.

The committee will advise NAPT on critical issues including advancing clinical research collaboration, patient education and equitable insurance reimbursement practices.

Chaired by J. Isabelle Choi, clinical director and research director of the New York Proton Center and Assistant Member at Memorial Sloan Kettering Cancer Center, the committee is comprised of national leaders in radiation oncology and proton therapy including:

  • Gopal Bajaj, Inova Schar Cancer Institute Proton Therapy Center,

  • Brian Baumann, S. Lee Kling Center for Proton Therapy at the Siteman Cancer Center,

  • Jeff Bradley, Emory Proton Therapy Center,

  • Andrew Chang, California Protons Cancer Therapy Center,

  • Steve Frank, MD Anderson Cancer Center Proton Therapy Center,

  • James Gray, Provision CARES Proton Therapy Center,

  • Brandon Gunn, MD Anderson Cancer Center Proton Therapy Center,

  • Nancy Mendenhall, University of Florida Health Proton Therapy Institute,

  • Minesh Mehta, Miami Cancer Institute Proton Therapy Center at Baptist Health South Florida,

  • Charles Simone, New York Proton Center,

  • Christina Tsien, The Johns Hopkins National Proton Center,

  • Torunn Yock, Francis Burr Proton Therapy Center at Massachusetts General Hospital,

  • Jing Zeng, Seattle Cancer Care Alliance Proton Therapy Center.

Under Choi’s leadership, the NAPT Physician Advisory Committee will promote the benefits of proton therapy. The committee will attend advocacy meetings with federal and state government agencies and members of Congress, collaborate with other cancer-related stakeholders, and support proton therapy research.

Previously, Choi was an assistant professor at the University of Maryland School of Medicine and served as a clinical lead of the Maryland Proton Treatment Center.

Table of Contents

YOU MAY BE INTERESTED IN

Despite steady progress in reducing overall cancer mortality rates, cancer incidence in women is rising, according to the American Cancer Society’s “Cancer Statistics, 2025” report. Incidence rates in women 50-64 years of age have surpassed those in men, and rates in women under 50 are now 82% higher than their male counterparts, up from 51% higher in 2002. In 2021, for the first time, lung cancer incidence was higher in women under 65 than in men. 
Over the past five years, Cedars-Sinai Cancer has built an integrated, regional system designed to provide cancer care close to where patients live and work. This model of care, directed by an academic medical center to patients at the community level, proved to be the best possible approach to supporting patients in our 11-million-person catchment area during the worst fire disaster in California history. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login